Physician profile
Nitin Na Agarwal
NPI 1154587863
$63,760.45
in general payments reported to CMS, 2019-2025
15 companies · $34K in 2025
The $34K reported for 2025 was more than what 96% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,617 · 2020: $950 · 2021: $502 · 2022: $5,447 · 2023: $5,722 · 2024: $7,561 · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $11K · Travel and Lodging: $4,156 · Honoraria: $3,225 · Food and Beverage: $2,295 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,502.00 |
| Consulting Fee | $11,050.00 |
| Travel and Lodging | $4,156.15 |
| Honoraria | $3,225.00 |
| Food and Beverage | $2,294.79 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $35,953.16 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Ionis Pharmaceuticals, INC. | $12,309.62 | 2025 | |
| Eisai INC. | $7,313.54 | 2019 | |
| Lundbeck LLC | $4,408.48 | 2025 | |
| Monteris Medical Corporation | $1,745.71 | 2019 | |
| Nuvasive, INC. | $781.68 | 2019-2023 | Pulse, Tlx |
| Medical Device Business Services, INC. | $310.00 | 2019 | |
| Depuy Synthes Sales INC. | $291.16 | 2022-2025 | Conduit, Trialtis, Velys |
| Zimmer Biomet Holdings, INC. | $210.30 | 2021-2024 | Rosa |
| Abbott Laboratories | $175.02 | 2022 | |
| Neuropace, INC. | $129.19 | 2021 | |
| Globus Medical, INC. | $85.63 | 2023 | Excelsiusgps Robotic Navigation System |
| Pyros Pharmaceuticals, INC. | $30.24 | 2024 | Vigpoder |
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.